As I was getting up from my visit with Mrs. Gregory, her right hand went to the base of her neck. Dr. Smith, do you think ...
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...
News-Medical.Net on MSN
New tool can predict cancer recurrence risk in patients with pancreatic neuroendocrine tumors
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...
News-Medical.Net on MSN
Skipping sentinel lymph node biopsy may be safe for some early-stage breast cancer patients
Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, ...
A team of oncology navigators at OhioHealth Mansfield Hospital is available to help cancer patients with problems of all ...
In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...
Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...
Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells ...
Less-invasive lymph node procedures are noninferior to axillary lymph node dissection for 3-year recurrence outcomes in breast cancer patients.
Preoperative radiation improved T-cell infiltration among patients with hormone receptor-positive, HER2-negative breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback